Subtyping of human cellular prion proteins and their differential solubility

[1]  H. Karch,et al.  Differential solubility of prions is associated in manifold phenotypes , 2009, Molecular and Cellular Neuroscience.

[2]  Thomas Arnold,et al.  The Use of Detergents to Purify Membrane Proteins , 2008, Current protocols in protein science.

[3]  J. Hauw,et al.  Regulating Factors of PrPres Glycosylation in Creutzfeldt-Jakob Disease - Implications for the Dissemination and the Diagnosis of Human Prion Strains , 2008, PloS one.

[4]  J. Manson,et al.  Host PrP Glycosylation: A Major Factor Determining the Outcome of Prion Infection , 2008, PLoS biology.

[5]  H. Karch,et al.  Regional and phenotype heterogeneity of cellular prion proteins in the human brain , 2007, The European journal of neuroscience.

[6]  J. Grassi,et al.  Immunoreactivity enhancement with chelators for increasing the detection sensitivity of human PrPSc by Western blotting , 2007, Neurochemistry International.

[7]  J. McGeehan,et al.  Insoluble Aggregates and Protease-resistant Conformers of Prion Protein in Uninfected Human Brains* , 2006, Journal of Biological Chemistry.

[8]  R. Riek,et al.  The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro. , 2006, Biochemistry.

[9]  J. Langeveld,et al.  Immunopathology and Infectious Diseases Detection of Type 1 Prion Protein in Variant Creutzfeldt-Jakob Disease , 2005 .

[10]  A. Aguzzi,et al.  Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease , 2005, The Lancet Neurology.

[11]  J. Collinge,et al.  Regional heterogeneity of cellular prion protein isoforms in the mouse brain. , 2003, Brain : a journal of neurology.

[12]  Detlev Riesner,et al.  Biochemistry and structure of PrP(C) and PrP(Sc). , 2003, British medical bulletin.

[13]  Pauline M Rudd,et al.  Glycosylation and prion protein. , 2002, Current opinion in structural biology.

[14]  I. Vorberg,et al.  Molecular Basis of Scrapie Strain Glycoform Variation* , 2002, The Journal of Biological Chemistry.

[15]  C. Soto,et al.  Cyclic amplification of protein misfolding: application to prion-related disorders and beyond , 2002, Trends in Neurosciences.

[16]  Tong Liu,et al.  Heterogeneity of normal prion protein in two‐dimensional immunoblot: presence of various glycosylated and truncated forms , 2002, Journal of neurochemistry.

[17]  J. Collinge,et al.  Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay , 2001, The Lancet.

[18]  D. Dormont,et al.  New insight into abnormal prion protein using monoclonal antibodies. , 1999, Biochemical and biophysical research communications.

[19]  S. Prusiner,et al.  Glycosylation differences between the normal and pathogenic prion protein isoforms. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  V. Daggett,et al.  PrPc glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains. , 1999, Journal of neuropathology and experimental neurology.

[21]  R. Dwek,et al.  Glycoproteins: glycan presentation and protein-fold stability. , 1999, Structure.

[22]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[23]  B. Ghetti,et al.  Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. , 1998, The American journal of pathology.

[24]  B. Faucheux,et al.  Cellular prion protein localization in rodent and primate brain , 1998, The European journal of neuroscience.

[25]  M. Groschup,et al.  Generation of Monoclonal Antibodies against Human Prion Proteins in PrP0/0 Mice , 1996, Molecular medicine.

[26]  Andrew F. Hill,et al.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.

[27]  D. Teplow,et al.  Truncated Forms of the Human Prion Protein in Normal Brain and in Prion Diseases (*) , 1995, The Journal of Biological Chemistry.

[28]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Caughey.  Scrapie associated PrP accumulation and its prevention: insights from cell culture. , 1993, British medical bulletin.

[30]  K. Kato,et al.  High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[31]  S. Prusiner,et al.  Prions and prion proteins 1 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  S. Prusiner,et al.  Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Prusiner,et al.  Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. , 1990, Biochemistry.

[34]  D. Schmechel,et al.  Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. , 1987, Annual review of neuroscience.

[35]  S. Prusiner,et al.  Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. , 1980, Biochemistry.

[36]  N. Tolbert,et al.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. , 1978, Analytical biochemistry.

[37]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.